Leading researchers in cancer treatment have made a breakthrough at the Nottingham University after a trial of 1,000 patients in the city.
The Nottingham Prognostic Response Index, has become one of the leading researchers in identifying and the treatment of cancer. New methods are being tried where chemotherapy is used before surgery to identify personalised patients needs.
As the charity Cancer Research recently announced half of people born after 1960 will get cancer, this breakthrough in treatment has been well received by both patients and doctors alike.
It was also reported that, even though the risk of being diagnosed is higher, the survival rates for cancer patients have risen.
Dr Stephen Chan, the clinical lead on the breast cancer research team at Nottingham City Hospital said ‘This is the new breakthrough in cancer treatment, it’s moving us closer to a more viable cure.’